Table 1.
Patients suffering from NSCLC and on TKI treatment were divided into two groups based on T790M positivity
| Group 1 patients | |
| Sample size | 25 |
| Mutational status | T790M negative (mixture of L858R and exon19 del) |
| Age | 45–70 |
| Gender | |
| Male | 15 |
| Female | 10 |
| Smoker status | |
| Yes | 20 |
| No | 5 |
| Disease stage | IV |
| Histology | Adenocarcinoma |
| Group 2 patients | |
| Sample size | 25 |
| Mutational status | T790M positive (mixture of L858R and exon19 del) |
| Age | 56–68 |
| Gender | |
| Male | 16 |
| Female | 9 |
| Smoker status | |
| Yes | 18 |
| No | 7 |
| Disease stage | IV |
| Histology | Adenocarcinoma |
| Healthy volunteers | |
| Sample size | 25 |
| Age | 40-67 |
| Gender | |
| Male | 15 |
| Female | 10 |
| Smoker status | |
| Yes | 25 |
| No | 0 |